Novel Genomic Risk Stratification Model for Primary Gastrointestinal Stromal Tumors (GIST) in the Imatinib and Adjuvant Therapy Era.
Josephine Kam Tai K DermawanCiara M KellyZhidong GaoShaleigh A SmithBhumika JadejaSamuel SingerWilliam D TapPing ChiCristina R AntonescuPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
We developed a novel, next-generation genomic risk stratification model for primary gastric and small bowel GISTs, complementing traditional clinicopathologic models. Future independent validation of our model in external cohorts is essential.
Keyphrases